CIK 0000925741 · Non-accelerated filer<br>Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232753988
- Phone
- 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- Open-market buys, last 90 days
- $9,394
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,394. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Facteau Bill Director | Grant or award · Stock Option (right to buy) | +12,000 | 15,729 | ||
| 2025-12-08 | STERTZER SIMON H Director | Grant or award · Stock Option (right to buy) | +12,000 | 15,573 | ||
| 2025-12-08 | Blank Andrew Scott Director | Grant or award · Stock Option (right to buy) | +12,000 | 15,313 | ||
| 2025-12-08 | Slosman Marvin Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-09-19 | STERTZER SIMON H Director | Purchase | +398,400 | $1.25 | $498K | 591,054 |
| 2025-09-19 | STERTZER SIMON H Director | Purchase · Warrant (right to buy) | +398,400 | 575,675 | ||
| 2025-09-19 | Blank Andrew Scott Director | Purchase | +288,000 | $1.25 | $360K | 634,023 |
| 2025-09-19 | Blank Andrew Scott Director | Purchase · Warrant (right to buy) | +288,000 | 602,522 | ||
| 2025-09-19 | Altman Peter President and CEO | Purchase | +48,000 | $1.25 | $60K | 216,762 |
| 2025-09-19 | Altman Peter President and CEO | Purchase · Warrant (right to buy) | +48,000 | 143,612 | ||
| 2025-08-22 | Altman Peter President and CEO | Purchase | +700 | $1.83 | $1K | 168,762 |
| 2025-08-13 | Altman Peter President and CEO | Purchase | +100 | $1.83 | $183 | 168,062 |
| 2025-08-12 | Altman Peter President and CEO | Purchase | +400 | $1.75 | $700 | 167,962 |
| 2025-08-11 | Altman Peter President and CEO | Purchase | +1,700 | $1.76 | $3K | 167,562 |
| 2025-06-30 | McClung David Chief Financial Officer | Purchase | +4,819 | $2.08 | $10K | 47,950 |
| 2025-06-30 | McClung David Chief Financial Officer | Purchase · Warrant (right to buy) | +4,819 | 26,275 | ||
| 2025-06-30 | Altman Peter President and CEO | Purchase | +24,096 | $2.08 | $50K | 165,862 |
| 2025-06-30 | Altman Peter President and CEO | Purchase · Warrant (right to buy) | +24,096 | 95,612 | ||
| 2025-06-30 | STERTZER SIMON H Director | Purchase | +72,289 | $2.08 | $150K | 192,654 |
| 2025-06-30 | STERTZER SIMON H Director | Purchase · Warrant (right to buy) | +72,289 | 177,275 |
Page 4 of 14 · 273 trades